Navigation Links
New Vaccine to Control Blood Pressure

Brittish scientists have develop a vaccine which they claim will help people suffering from hypertension to control their blood pressure .

The vaccine developed by Cheshire-based drug firm Protherics has been successfully tested and is expected in the markets within five years.

The vaccine uses a protein found in limpets, a sea creature, to attack a hormone called angiotensin produced by the liver. Angiotensin raises blood pressure by narrowing arteries. The vaccine, however, turns the body's immune system against the hormone.

It would need a course of just three jabs, with a booster every six months.

A booster shot every six months, or even once a year, would keep blood pressure low, the researchers said.

People who have tried it have suffered a few side effects, although one in ten did complain of a brief flu-like illness.

Protherics is planning trials of an improved version of the vaccine, which is ten times more effective at stimulating the immune system than its original formula, the Daily Mail reported.

"Improving compliance in this way could save thousands from life-threatening complications such as heart attack or stroke," said Andrew Heath, an official of Protherics.

High blood pressure which affects a third of all adults doubles the risk of dying from heart disease or stroke and is blamed for 60,000 deaths a year in Britain. It is currently treated with pills with side effects and some patients simply stop taking them.

The Swiss firm Cytos Biotechnology is also developing a similar vaccine that uses an empty virus shell to spur the immune system into action.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Vaccine Control Blood Pressure

(Date:11/25/2009)...tiative expands to include cost-effective, sustain... healthcare professionals in developing world. , ...ember 25, 2009 -- Elluminate, Inc. , the leader i...ns that support 21st century teaching, learning, ...and Ice initiative was awarded iNACOL,s first-ev...
(Date:11/25/2009)...RNewswire/--dazzlesmile,llc www.dazzlesmile.com an....com havefileda67-pagefederallawsuitagainstEpicAdv...ms,FarendServicesLimited,andAtLastFulfillment.The1...ourtfortheDistrictofUtah,allegesmassivenationalcon...eethwhiteningproducts,violationsoftheRacketeeringI...
(Date:11/25/2009)...in French and Spanish . , , Researchers... early diagnosis of certain ocular diseases that a...degeneration and keratitis, by applying an existin...before been used for this purpose. , Scientists ...ubjects affected by one of these two pathologies, ...
(Date:11/25/2009)...icians at UT Southwestern Medical Center soon will... breathing in patients with upper spinal-cord inju...ng independently. , UT Southwestern University ...n Texas and one of 25 in the country currently equ...hragm Pacing System. , The device is designed to...
(Date:11/25/2009)...ing support for recent enforcement actions against...sociation of Chain Drug Stores (NACDS) submitted a... The letter expresses the Association’s con... foreign, that are engaged in a pattern of illegal... of prescription medications. , ...
Breaking Medicine News(10 mins):Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:NACDS Supports FDA Enforcement Against Rogue Internet Pharmacy Websites 2
...ld Lester Boggs whose lackadaisical attitude towar... the cause of his death// when he apparently expos...n Sept. 3 at St. John's Hospital marking Sangamon ...virus. Boggs' wife of 66 years, Mary Boggs, ...
...officials have announced a hike of 5.6 percent for...ides this premiums for the wealthier// beneficiari...rst time the federal government has required the a...vering doctor visits and outpatient hospital care,...
... to a Japanese study, there has been a significant...ases, due to drinking of green tea//. A 25 ...sease was reported in this study conducted on more...the diet in the west. The findings of this...
...inflammatory drug colchicine, which is often used ...preventing liver cancer// in patients with hepatit...researchers said in a new study. The study f... the Instituto Nacional de Cancerologia, Mexico Ci...
...he safest pain medication? Many people with osteoa...r studies linked the painkillers called COX-2 inhi...le with arthritis have switched from a COX-2 drug ...ctive at reducing pain and inflammation, they can ...
...vation issue continues to haunt the prestigious Al... as the main poll plank// for the elections to its...ly Tuesday. Nearly 1,400 resident doctors, in... Sixteen Candidates are contesting the elections t...
Other Medicine News:Health News:91-year-old city man Falls Victim to West Nile Virus 2Health News:Medicare Premiums to be Higher Next Year 2Health News:Live long with Green tea!! 2Health News:Live long with Green tea!! 3Health News:AIIMS Goes to Polls Amid Reservation Issues 2
(Date:11/25/2009)...-NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompan...surgicaltreatmentsforthespine,announcedtodaythatit...5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocuson...sproductsandwillincludecommentsfrommanagementfollo...ersare1-877-407-4018fordomesticcallersand1-201-689...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 1LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 2Taxpayer Alliance applauds bill to broaden access to federal research results 9018 1Taxpayer Alliance applauds bill to broaden access to federal research results 9018 2T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 1T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 2
...ELBOURNE, Australia, Sept. 4 Cytopia Limited (ASX...ment for its Phase Ib/II,study of CYT997, the comp...n patients with an aggressive form of brain cancer... clinical trial is the first Phase II efficacy stu... the company and the second in its,suite of Phase ...
...nother Roche first in TaqMan(R) real-time PCR test... lab, PLEASANTON, Calif., Sept. 4 The U.S. ...Roche COBAS(R) TaqMan(R) HBV Test,the first assay ... the U.S.,The test uses Roche,s real-time PCR tech... DNA in a patient,s blood. Doctors may use viral l...
Other Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up
Full Handle Laseredge Crescent Blade Knife, angled bevel down
Medicine Products: